PPARA and obesity due to melanocortin 4 receptor deficiency: The upregulation of PPAR-α and CPT-1 in the liver following EQR treatment signifies enhanced fatty acid oxidation, a critical mechanism for reducing hepatic lipid accumulation in obesity.